MCUJF News and Press, Medicure Inc From 12/02/20

Medicure Retains Investor Relations Firm Renmark Financial Communications Inc. NEW INVESTOR SLIDE PRESENTATION AVAILABLE AT WWW.MEDICURE.COM/INVESTORS WINNIPEG, MB, Dec. 2, 2020 /CNW/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH) (OTC...

Medicure, Inc. (MCUJF) Q3 2020 Earnings Conference Call November 12, 2020, 08:30 ET Company Participants Albert Friesen - Founder, CEO & Chairman James Kinley - CFO & Secretary Neil Owens - President & COO Conference Call Participants Sam Rebotsky - SER Asset Management Presentati...

Medicure Reports Financial Results for Quarter Ended September 30, 2020 PR Newswire WINNIPEG, MB, Nov. 11, 2020 WINNIPEG, MB , Nov. 11, 2020 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC:MCUJF), a cardiovascular pharma...

Medicure Q3 2020 Results and Conference Call Dates Canada NewsWire WINNIPEG, MB, Nov. 5, 2020 WINNIPEG, MB, Nov. 5, 2020 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a cardiovascular pharmaceutical company, will release finan...

Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar PR Newswire WINNIPEG, AB, Oct. 5, 2020 WINNIPEG , AB, Oct. 5, 2020 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) ...

Ultra-thinly traded nano cap Medicure ( OTCPK:MCUJF +22.5% ) is up on a 20x surge in volume, a scant 29K shares, on reaction to investigator reports that Aggrastat (tirofiban hydrochloride) may be effective in preventing and treating thrombotic (clotting) complications associated with CO...

WINNIPEG, MB , Aug. 24, 2020 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is reporting that early investigator sponsored clinical reports evaluating the efficacy of AGGRASTAT ®  (tirofiban hydrochloride) sho...

STRENGTHENS FOCUS ON MARKETING OF AGGRASTAT ®  AND ZYPITAMAG TM WINNIPEG, MB , Aug. 20, 2020 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced the termination of the marketing and...

The following slide deck was published by Medicure Inc. in conjunction with their 2020 Q2 earnings Read more ...

Medicure, Inc. (MCUJF) Q2 2020 Earnings Conference Call August 12, 2020 8:30 AM ET Company Participants Albert Friesen - Chief Executive Officer James Kinley - Chief Financial Officer Neil Owens - President and Chief Operating Officer Conference Call Participants Sam Rebots...